Matching-Adjusted Indirect Comparison of Current Treatments for NMOSD and Evaluation of Long-Term Effectiveness

被引：0
|
作者：
Paul, Friedemann [1 ]
Aktas, Orhan [2 ]
Pedersen, Mikkel [3 ]
Vilela, Francisco Sorio [4 ]
Patterson, Kristina [4 ]
Rampal, Nishi [4 ]
Cimbora, Daniel [4 ]
Cree, Bruce [5 ]
机构：
[1] Max Delbruck Ctr Mol Med, Berlin, Germany
[2] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany
[3] Incentive, Holte, Denmark
[4] Horizon Therapeut, Deerfield, IL USA
[5] UCSF, Weill Inst Neurosci, San Francisco, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P011/1038
引用
收藏
页码：144 / 145
页数：2
相关论文
共 50 条
  • [21] MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC): SENSITIVITY ANALYSES AND GRAPHICAL DIAGNOSTICS
    Signorovitch, J.
    Cao, W.
    Rybkin, V
    Yao, Z.
    Hellstern, M.
    VALUE IN HEALTH, 2017, 20 (09) : A771 - A771
  • [22] Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison
    Phillippo, David M.
    Dias, Sofia
    Ades, A. E.
    Welton, Nicky J.
    RESEARCH SYNTHESIS METHODS, 2020, 11 (04) : 568 - 572
  • [23] Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
    Signorovitch, James E.
    Sikirica, Vanja
    Erder, M. Haim
    Xie, Jipan
    Lu, Mei
    Hodgkins, Paul S.
    Betts, Keith A.
    Wu, Eric Q.
    VALUE IN HEALTH, 2012, 15 (06) : 940 - 947
  • [24] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
    Rand, Kim
    Ramos-Goni, Juan Manuel
    Akmaz, Bulent
    Sole-Feu, Laia
    Armario-Hita, Jose-Carlos
    DERMATOLOGY AND THERAPY, 2024, 14 (01) : 169 - 182
  • [25] Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis
    Samjoo, Imtiaz A.
    Worthington, Evelyn
    Haltner, Anja
    Cameron, Chris
    Nicholas, Richard
    Rouyrre, Nicolas
    Dahlke, Frank
    Adlard, Nicholas
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (07) : 1157 - 1166
  • [26] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
    Kim Rand
    Juan Manuel Ramos-Goñi
    Bülent Akmaz
    Laia Solé-Feu
    José-Carlos Armario-Hita
    Dermatology and Therapy, 2024, 14 : 169 - 182
  • [27] A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit / hyperactivity disorder: long-term safety and efficacy
    Schein, Jeff
    Cloutier, Martin
    Gauthier-Loiselle, Marjolaine
    Catillon, Maryaline
    Xu, Chunyi
    Qu, Alice
    Lee, Francesca
    Childress, Ann
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (09)
  • [28] A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons
    Cassidy, Owen
    Harte, Marie
    Trela-Larsen, Lea
    Walsh, Cathal
    White, Arthur
    McCullagh, Laura
    Leahy, Joy
    VALUE IN HEALTH, 2023, 26 (11) : 1665 - 1674
  • [29] Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis
    Wang, Lin
    Paller, Channing
    Hong, Hwanhee
    Rosman, Lori
    De Felice, Anthony
    Brawley, Otis
    Alexander, G. Caleb
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (02): : 191 - 202
  • [30] A MATCHING-ADJUSTED INDIRECT COMPARISON OF EFGARTIGIMOD VERSUS RAVULIZUMAB FOR GENERALIZED MYASTHENIA GRAVIS
    Celico, L.
    Spaepen, E.
    De Francesco, M.
    Chiroli, S.
    Iannazzo, S.
    Ruck, T.
    Meuth, S. G.
    VALUE IN HEALTH, 2022, 25 (12) : S20 - S20
12345